**Core tip:** Choledochocele, also known as the type III choledochal cyst according to Todani's classification, is a rare disease. We present the case of an adult female with a large-size choledochocele that was successfully treated by open surgery. We also provide a detailed discussion of the recent literature on such cases and their therapeutic management.

INTRODUCTION
============

Choledochocele (also known as type III choledochal cyst according to Todani's classification\[[@B1]\]), is a cystic dilation of the distal segment of the common bile duct protruding into the duodenal lumen. Considered rare, these cases comprise less than 2% of all reported cases of choledochal cyst\[[@B2]\]. The rarity of the disease serves to obscure its diagnosis and treatment.

The case described herein, accompanied by a review of the current literature, will help to increase our knowledge about this rare disease.

CASE REPORT
===========

A 50-year-old woman was admitted to our department with an \> 10-year history of repeated upper abdominal pain, but without vomiting, jaundice, chills and fever. During that period, she had been admitted to the gastroenterology outpatient clinic several times, where she was diagnosed with and treated for chronic nonatrophic gastritis; yet, her symptom was never alleviated.

Physical examination produced no positive findings, except a mild tenderness on the upper abdomen. Routine blood panel, liver function markers, blood amylase and tumor marker test results were normal. Abdominal ultrasound showed gallstones and nondilated intrahepatic and extrahepatic bile ducts. As such, the cause of the patient's presenting symptom remained undetermined.

Multislice spiral computed tomography showed a 3.0 cm-long, 1.5 cm-wide cystic lesion at the junction of the descending and horizontal portion of the duodenum (Figure [1](#F1){ref-type="fig"}). Duodenoscopy was performed and showed a huge submucosal mass connected to the major duodenal papilla; the distal segment of the common bile duct was not evident in endoscopic retrograde cholangiopancreatography (ERCP) (Figure [2](#F2){ref-type="fig"}). We considered these findings to indicate a choledochocele, and we decided to treat with open surgical management.

![Multislice spiral computed tomography indicating a cystic lesion at the duodenum. Black arrows indicate the cystic lesion.](WJCC-6-842-g001){#F1}

![Duodenoscopy showing a huge submucosal mass connected to the major duodenal papilla. The distal segment of the common bile duct was not evident.](WJCC-6-842-g002){#F2}

The cystic lesion became grossly visible when the descending part of the duodenum was incised longitudinally, and complete cystectomy was performed (Figure [3](#F3){ref-type="fig"}). Then, the orifices of the common bile duct and pancreatic duct were found and each marked with 6-Fr silicon tube. Sphincteroplasty was performed under the guidance of the silicon tube. Cholecystectomy was also carried out to address the gallstones. An abdominal cavity drainage tube and a duodenostomy tube were placed. A T-tube was also placed, to facilitate external drainage of bile. Lastly, a nasojejunal nutrition tube was placed perioperatively, and enteral nutrition support was started on the 3^rd^ day after surgery. The operation time was 4 h and intraoperative blood loss was 120 mL. Postoperative pathological examination of the resected tissue showed duodenal mucosa with regional low-grade intraepithelial neoplasia inside the choledochocele.

![The cyst lesion was found to be attached to the duodenal papilla during the surgery.](WJCC-6-842-g003){#F3}

At 1 wk postoperation, the nasojejunal nutrition tube was removed and the duodenostomy tube was occluded; at this time, oral feeding was initiated and tolerated without event. The postoperative period remained uneventful, and the patient was discharged at 10 d after the operation. At 45 d postoperation, the T-tube and duodenostomy tube were removed. At the 1-year follow-up, the patient had survived and was asymptomatic.

DISCUSSION
==========

The first case of choledochocele was reported by Wheeler\[[@B3]\] in 1915. The report described the anomaly as a small, tense cyst occupying a position in or about the orifice of the common bile duct\[[@B3]\]. Since then, with the development of medical techniques like endoscopy and imaging, the number of publications on choledochocele has steadily increased.

In 1993, Masetti et al\[[@B4]\] reviewed 116 cases of choledochocele reported in the literature to date. In 2015, Lobeck et al\[[@B5]\] reviewed 71 individual case reports as well as 42 institutional reviews, totaling 254 cases of choledochocele; unfortunately, the authors did not affirm whether or not there were duplications between the included cases. A single case series of choledochocele including 28 patients was reported by Ziegler et al\[[@B6]\] in 2009, representing the largest institution-based collection of case data. In this article, we summarized 22 case report studies of adult choledochocele patients receiving treatment between 1995 and 2015 in PubMed database (Table [1](#T1){ref-type="table"}).

###### 

Case report studies of adult choledochocele patients receiving treatment, 1995-2015

  **Author**       **Clinical presentation**   **Treatment**   **Malignancy**   **Symptom relief**
  ---------------- --------------------------- --------------- ---------------- --------------------
  Eisenman 1995    Abdominal pain              ET              Not noted        Yes
  Tajiri 1996      Abdominal pain              OST             No               Yes
  Tanno 1996       Jaundice, fever             ET              Not noted        Yes
  Krepel 1997      Anaemia, Abdominal pain     OST             No               Yes
  Iwata 1998       Abdominal pain, fever       OST             No               Not noted
  Chatila 1999     Abdominal pain              ET              No               Yes
  Adamek 2000      Nausea, abdominal pain      ET              Not noted        Yes
  Groebli 2000     Abdominal pain              OST             Not noted        Not noted
  Can 2006         Abdominal pain              OST             Not noted        Yes
  Moparty 2006     Abdominal pain              OST             Not noted        Not noted
  Berger 2007      Abdominal pain, nausea      ET              No               Yes
  Hackert 2007     Abdominal pain              OST             No               Not noted
  Izumiya 2007     Abdominal pain              ET              Not noted        Yes
  Kawakami 2007    None                        ET              No               \-
  Lakhtakia 2007   Abdominal pain, vomit       ET              No               Yes
  Kaye 2008        Abdominal pain              OST             Not noted        Yes
  Park 2009        Abdominal pain              ET              No               Yes
  Amezaga 2010     Jaundice, anorexia          ET              Not noted        Yes
  Cakmakci 2012    Abdominal pain              OST             Not noted        Yes
  Darji 2012       Abdominal pain, vomit       ET              Not noted        Not noted
  Zhu 2014         Abdominal pain, vomit       ET              Not noted        Yes
  Villa 2015       Abdominal pain              ET              Not noted        Yes

OST: Open surgical treatment; ET: Endoscopic treatment.

In Japan, choledochocele has been regarded as the type III choledochal cyst (according to Todani's classification\[[@B1]\]) and reportedly accounts for the lowest proportion of choledochal cyst case series\[[@B2]\]. However, both Ziegler et al\[[@B6]\] and Dong et al\[[@B7]\] considered that the choledochal cysts should not include the choledochocele because patients with choledochocele differ from those with choledochal cyst in age, sex, presentation, pancreatic ductal anatomy, and their management. Choledochoceles were classiﬁed as type A and type B based on the anatomic appearance by Sarris and Tsang, and the type A Choledochoceles were further divided into 3 subtypes (intraluminal with common opening for the common bile duct and pancreatic duct, intraluminal with separate openings for the common bile duct and pancreatic duct and completely intramural)\[[@B8]\]. Other classifications had also been proposed like Kagiyama\[[@B9]\] and Horaguchi\[[@B10]\], however none has been widely accepted.

The etiology of the choledochocele remains unclear. Tanaka\[[@B11]\] suggested that the mechanism for formation was failed regression of a bile duct during embryogenesis. However, Sterling\[[@B12]\] considered that some choledochocele appear to be acquired and proposed that papillary stenosis or sphincter of Oddi dysfunction may cause obstruction to bile flow, resulting in increased pressure within the distal bile duct, which could then evaginate into the duodenum. Sarris and Tsang\[[@B8]\], in the review of 24 patients, reported that the epithelium inside the choledochocele was duodenal mucosa in 63% of the cases and biliary tract epithelium or unclassifiable glandular epithelium in 37% of the cases.

In histopathology, the presence of intestinal mucosa creates controversy as to whether choledochocele is a type of duodenal duplication cyst or a unique entity. Congenital intraluminal duodenal diverticulum has been suggested in relation to the pathogenesis of choledochocele in young children, because most cases describe duodenal mucosa. However, unlike congenital forms, in older patients a papillary stenosis may cause dilatation of the ampulla by way of an inflammatory process induced by stasis of bile and pancreatic juice. Thus, biliary tract epithelium and undifferentiated epithelium are predominant later on\[[@B13]\].

Abdominal pain is the most common symptom of choledochocele, others include nausea, vomiting and jaundice. Image examination plays an important role in the diagnosis. Noninvasive B-ultrasound examination can detect cystic mass in the duodenal cavity; however, the image could be disturbed by intestinal gas. Usually, there are no specific findings, as in our case. Endoscopic ultrasound could show the wall layers of the cyst as well as the connection with the pancreaticobiliary tree, it also might guide both classification of the lesion and treatment decisions\[[@B14]\]. Some think the confirmation of a choledochocele appears to be best made by ERCP.

In the literature, ERCP has been performed in 67% of the reported cases, and this method holds the benefit of simultaneous treatment implementation. Multislice spiral computed tomography and magnetic resonance cholangiopancreatography are considered to have comparable specificity and sensitivity, and may replace ERCP for diagnosis\[[@B15],[@B16]\]. In our patient, both endoscopic and radiologic techniques were used to obtain an optimal image.

Open surgical management, like transduodenal complete cyst excision with sphincteroplasty, was performed by Wheeler on the original choledochocele case (a 65-year-old male patient) with success, and is still frequently performed. In 1974, endoscopic sphincterotomy treatment was implemented for the first time by Mane et al\[[@B17]\], on a 21-year-old female patient. Since then, endoscopy has been recognized as a feasible alternative treatment with satisfactory results. Both therapies have been applied successfully in pediatric patients\[[@B18],[@B19]\].

The choice of treatment method is still uncertain, however, and size of the cyst plays a role in the clinical decision-making process. Three centimeters in diameter may be the cut-off value, above which transduodenal cyst resection should be performed\[[@B5]\]. However, the fundamental purpose of choledochocele treatment should be to maintain normal outflow of bile and pancreatic juice, with the additional objective of minimizing risk of malignancy. The large diameter of the cyst lesion in our patient led us to decide to perform open surgery. Almost all of the patients have relieved after treatment either by endoscopy or surgery. Malignant transformation of a choledochocele has been rarely reported\[[@B20]\], and wasn't happened in the case reports we reviewed in the table. However, choledochocele might be accompanied or caused by pancreaticobiliary maljunction, in such a condition, biliary tract malignancy was more frequent according to Horaguchi's report\[[@B10]\]. Nonetheless, sustaining follow-up could be beneficial for patients who are asymptomatic or accidentally discovered.

In conclusion, choledochocele is a rare disease and the choice of treatment method is still controversial. For choledochocele with large-size (*i.e*., \> 3 cm in diameter), we suggest treatment with open surgical management, according to our case's successful outcome.

ARTICLE HIGHLIGHTS
==================

Case characteristics
--------------------

A 50-year-old woman with upper abdominal pain lasting for more than 10 year.

Clinical diagnosis
------------------

Choledochocele.

Laboratory diagnosis
--------------------

No positive laboratory test results were found.

Imaging diagnosis
-----------------

A 3.0 cm-long, 1.5 cm-wide cystic lesion at the junction of the descending and horizontal portion of the duodenum.

Pathological diagnosis
----------------------

Duodenal mucosa with regional low-grade intraepithelial neoplasia inside the choledochocele.

Treatment
---------

Open surgical management involving cyst excision with sphincteroplasty.

Related reports
---------------

Choledochocele is considered a rare disease, and cases are seldom reported.

Term explanation
----------------

Choledochocele, also known as the type III choledochal cyst according to Todani's classification, is a cystic dilation of the distal segment of the common bile duct protruding into the duodenal lumen, and accounts for \< 2% of all reported cases of choledochal cyst.

Experiences and lessons
-----------------------

Choledochocele is a rare disease and usually misdiagnosed as peptic ulcer. For the choledochocele with large size (*i.e*., \> 3 cm in diameter), we suggest treatment with open surgical management, according to our case's successful outcome.
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